Close
Indegene had a successful stock market debut, listing at Rs 659.70, a 46% premium over its issue price of Rs 452 per share on the BSE. Despite trading at Rs 579.90 with a 28% premium over the issue price, it fell 12% from its listing price on the BSE. The stock saw a healthy response with the IPO being subscribed 70.30 times.
Indegene, a healthcare research, analytics, and technology company, operates with a unique business model and has strong client relationships with top global biopharmaceutical companies. The company offers services to 65 clients and operates through an AI and ML-based proprietary platform. Analysts see Indegene as a leading provider of digital-led commercialization services tailored for the life sciences industry, with a focus on advanced tech solutions and deep domain expertise.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
